A group of medical researchers working at Georgetown University, the University of Rochester and UC-Irvine have developed a blood test which predicts with 90 percent accuracy if an individual will develop Alzheimer’s disease or mild cognitive impairment (MCI) within three years. The test, which looks for a set of ten lipid markers, will allow treatments to be sought that may be effective during this early, asymptomatic stage of the disease.
via Gizmag
Image: US National Institutes of Health
